Pharmacological inhibition of fatty acid synthase (FAS): a novel therapeutic approach for breast cancer chemoprevention through its ability to suppress Her-2/neu (erbB-2) oncogene-induced malignant transformation. (Q42825125)

From Wikidata
Jump to navigation Jump to search
scientific article published on November 2004
edit
Language Label Description Also known as
English
Pharmacological inhibition of fatty acid synthase (FAS): a novel therapeutic approach for breast cancer chemoprevention through its ability to suppress Her-2/neu (erbB-2) oncogene-induced malignant transformation.
scientific article published on November 2004

    Statements

    title
    Pharmacological inhibition of fatty acid synthase (FAS): a novel therapeutic approach for breast cancer chemoprevention through its ability to suppress Her-2/neu (erbB-2) oncogene-induced malignant transformation (English)
    1 reference
    stated in
    Europe PubMed Central
    PubMed publication ID
    15390078
    reference URL
    https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15390078%20AND%20SRC:MED&resulttype=core&format=json
    retrieved
    2 January 2020

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit
                      Retrieved from "https://www.wikidata.org/w/index.php?title=Q42825125&oldid=1584387822"